Issue Date: April 27, 2015
Peptide Manufacturers Stake Out Their Positions
The hermetic world of bulk peptide manufacturing brought forth news in February when one of the four major players, Bachem, acquired American Peptide, a midsized firm in Sunnyvale, Calif. The deal, which includes a plant not far from Bachem’s U.S. facility in Torrance, Calif., did little to alter the competitive landscape in peptides, however, other than to give the Swiss firm access to production capacity, in case something happens in peptides.
Like others . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society